Cancer treatment and survivorship statistics, 2025
CA: A Cancer Journal for Clinicians · 2025-08 · 75 (4) · 308-340
DOI: 10.3322/caac.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 30.05.2025. Verfasst von Nikita Sandeep Wagle und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Surveillance Research, American Cancer Society, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Neoplasms, Cancer Survivors, Survivorship. Die Arbeit wurde bisher 282-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment‐related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I‐II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi‐level efforts to expand access to high‐quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Surveillance Research, American Cancer Society, Atlanta, Georgia, USA.
- Health Services Research, American Cancer Society, Atlanta, Georgia, USA.
- Statistical Research and Applications Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
- Cancer Disparity Research, American Cancer Society, Atlanta, Georgia, USA.
- Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
- Medical & Health Content, American Cancer Society, Atlanta, Georgia, USA.
ORCID-Profile: Nikita Sandeep Wagle, Leticia Nogueira, Theresa P Devasia, K Robin Yabroff, Farhad Islami, Patricia A Ganz, Rebecca L Siegel
Zitieren
APA
Wagle, N. S., Nogueira, L., Devasia, T. P., Mariotto, A. B., Yabroff, K. R., Islami, F., Jemal, A., Alteri, R., Ganz, P. A., & Siegel, R. L. (2025). Cancer treatment and survivorship statistics, 2025. CA: A Cancer Journal for Clinicians, 75(4), 308-340. https://doi.org/10.3322/caac.70011
Vancouver
Wagle NS, Nogueira L, Devasia TP, Mariotto AB, Yabroff KR, Islami F, et al. Cancer treatment and survivorship statistics, 2025. CA: A Cancer Journal for Clinicians. 2025;75(4):308-340. doi:10.3322/caac.70011
BibTeX
@article{Wagle2025,
author = {Wagle, Nikita Sandeep and Nogueira, Leticia and Devasia, Theresa P and Mariotto, Angela B and Yabroff, K Robin and Islami, Farhad and Jemal, Ahmedin and Alteri, Rick and Ganz, Patricia A and Siegel, Rebecca L},
title = {Cancer treatment and survivorship statistics, 2025},
journal = {CA: A Cancer Journal for Clinicians},
year = {2025},
volume = {75},
number = {4},
pages = {308--340},
doi = {10.3322/caac.70011}
}
EUVIMED